[DArg10, Aib20]TLQP-21, also known as a TLQP-21 analogue, functions as a C3aR partial agonist and a C3aR functional antagonist (with a beta-arrestin recruitment EC50 of 854 nM). It does not exhibit significant calcium ion influx activity or enhanced adrenergic-induced lipolytic activity. This compound is applicable in research concerning inflammatory diseases, metabolic disorders, and neurological conditions.
Target-Kategorie:
Complement System
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
